Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Free Radic Biol Med ; 38(12): 1594-603, 2005 Jun 15.
Article in English | MEDLINE | ID: mdl-15917188

ABSTRACT

Metabolic responses of mammalian cells toward declining oxygen concentration are generally thought to occur when oxygen limits mitochondrial ATP production. However, at oxygen concentrations markedly above those limiting to mitochondria, several mammalian cell types display reduced rates of oxygen consumption without energy stress or compensatory increases in glycolytic ATP production. We used mammalian Jurkat T cells as a model system to identify mechanisms responsible for these changes in metabolic rate. Oxygen consumption was 31% greater at high oxygen (150-200 microM) compared to low oxygen (5-10 microM). Hydrogen peroxide was implicated in the response as catalase prevented the increase in oxygen consumption normally associated with high oxygen. Cell-derived hydrogen peroxide, predominately from the mitochondria, was elevated with high oxygen. Oxygen consumption related to intracellular calcium turnover was shown, through EDTA chelation and dantrolene antagonism of the ryanodine receptor, to account for 70% of the response. Oligomycin inhibition of oxygen consumption indicated that mitochondrial proton leak was also sensitive to changes in oxygen concentration. Our results point toward a mechanism in which changes in oxygen concentration influence the rate of hydrogen peroxide production by mitochondria, which, in turn, alters cellular ATP use associated with intracellular calcium turnover and energy wastage through mitochondrial proton leak.


Subject(s)
Hydrogen Peroxide/metabolism , Mitochondria/metabolism , Oxygen Consumption/drug effects , Oxygen/pharmacology , Adenosine Triphosphate/metabolism , Calcium/metabolism , Humans , Intracellular Membranes/drug effects , Intracellular Membranes/physiology , Jurkat Cells , Membrane Potentials/drug effects , Oxygen/administration & dosage
2.
J Neurochem ; 87(3): 764-72, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14535958

ABSTRACT

It has been widely hypothesized that neurons reduce cellular energy use in response to periods of energy deprivation. To test this hypothesis, we measured rates of energy use under normoxia and anoxia in immature (6 days in vitro) and mature (13 days in vitro) neuronal cultures. During anoxic incubation immature and mature cultures reduced cellular energy use by 80% and 45%, respectively. Reduced cellular energy use dramatically affected ATP depletion in neuronal cultures under anoxia. Intracellular ATP stores were expected to deplete within 3 min of anoxia. However, ATP was maintained at decreased but stabilized concentrations for at least 3 h. The capacity of neuronal cultures to reduce cellular energy use during anoxia correlated with their sensitivity towards simulated ischemia. Immature cultures, with the largest capacity to reduce cellular energy use, survived simulated ischemia 2.5 times longer than mature cultures. The addition of glutamate receptor antagonists to mature cultures further decreased cellular energy use during anoxia and significantly extended their survival time under simulated ischemia. This study verifies that primary cortical neuronal cultures reduce cellular energy use during energy deprivation. Additionally, we show that maturation of glutamate receptor activity increases non-depressible energy demand in neuronal cultures.


Subject(s)
Cell Hypoxia/physiology , Energy Metabolism/physiology , Neurons/metabolism , Adenosine Triphosphate/metabolism , Animals , Cells, Cultured , Cerebral Cortex/cytology , Excitatory Amino Acid Antagonists/pharmacology , Glucose/metabolism , Glutamic Acid/toxicity , Glycogen/metabolism , Neurons/cytology , Neurons/drug effects , Neurotoxins/toxicity , Oxygen/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Glutamate/drug effects , Receptors, Glutamate/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL